VKH
OREX

Virtu KCG Holdings’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Virtu KCG Holdings’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$41K Sell
14,238
-29,716
-68% -$89.1K ﹤0.01% 2636
2017
Q1 		$151K Buy
43,954
+10,139
+30% +$40K ﹤0.01% 2548
2016
Q4 		$59K Buy
33,815
+10,193
+43% +$24K ﹤0.01% 3056
2016
Q3 		$78K Sell
23,622
-2,849
-11% -$10.8K ﹤0.01% 2703
2016
Q2 		$114K Buy
26,471
+18,486
+232% +$83.6K ﹤0.01% 2508
2016
Q1 		$45K Sell
7,985
-1,107
-12% -$14.4K ﹤0.01% 2485
2015
Q4 		$156K Buy
9,092
+7,252
+394% +$173K ﹤0.01% 2839
2015
Q3 		$39K Sell
1,840
-1,404
-43% -$48.1K ﹤0.01% 3058
2015
Q2 		$161K Buy
3,244
+1,686
+108% +$101K ﹤0.01% 2713
2015
Q1 		$122K Sell
1,558
-4,689
-75% -$291K ﹤0.01% 2597
2014
Q4 		$379K Sell
6,247
-2,311
-27% -$116K 0.01% 2047
2014
Q3 		$365K Buy
8,558
+3,198
+60% +$172K 0.01% 2078
2014
Q2 		$331K Sell
5,360
-876
-14% -$50.9K 0.01% 2432
2014
Q1 		$405K Buy
+6,236
New +$422K 0.01% 2203
2013
Q4 		– Sell
-5,973
Closed -$366K – 4709
2013
Q3 		$366K Buy
+5,973
New +$405K ﹤0.01% 2383

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Virtu KCG Holdings's OREX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Orexigen Therapeutics, Inc. (OREX) stake by 68% in Q2 2017, selling an estimated $89.1K and leaving 14,238 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #2636.

Virtu KCG Holdings first reported a position in OREX in Q3 2013 and has held it in 15 quarters since. The position peaked at $405K in Q1 2014. 51 funds tracked by Wall St. Rank hold OREX as of Q2 2017.

  • Virtu KCG Holdings held 14,238 shares of Orexigen Therapeutics, Inc. worth $41K as of Q2 2017.
  • Virtu KCG Holdings sold 29,716 Orexigen Therapeutics, Inc. shares in Q2 2017, an estimated $89.1K.
  • Orexigen Therapeutics, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2636 holding.
  • Virtu KCG Holdings first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Orexigen Therapeutics, Inc. position peaked at $405K in Q1 2014.
  • 51 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.